PB
Probi AB (publ)
PBBIF · OTC
$24.00 +0.00% (+$0.00)
Market Cap $286.9M
P/E Ratio 160.00x
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
17 /100
Expensive P/E 160.00x
P/FCF 77.85x
EV/EBITDA 22.78x
Growth
2 /100
Declining EPS growth 46.69%
Book val. growth 0.16%
Rev. growth 10.81%
Profitability
33 /100
Weak Gross margin 35.25%
FCF margin 5.95%
Net margin 2.68%
Quality
11 /100
Poor ROIC 0.73%
Asset turnover 0.40x
ROA 1.08%
Debt
97 /100
Low Debt/Equity 0.04x
Net debt/EBITDA -2.36x
Current ratio 6.94x
Stability
76 /100
Stable Beta 0.44x
Profitable years 4
Rev. volatility 13.12%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PBBIF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Anita Johansen
Employees
157
Headquarters
Lund